Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Periodic Interim
confidence 95%
filed 2026-08-20
This is Petrobras's interim financial report for the six-month period ended June 30, 2026 (Jan-Jun/2026). The document presents consolidated financial statements including sales revenues (US$ 57,142 million), net income (US$ 16,627 million), cash flows, capital expenditures, debt metrics, and segment results. As a foreign private issuer's half-year financial report, it qualifies as a periodic_interim disclosure, not a discrete earnings event. The filing is material to investors as it provides comprehensive financial performance and liquidity data for the first half of 2026.
View raw filing on EDGAR →
6-K
Exec departure
confidence 95%
filed 2026-08-20
Mr. Maurício Augusto Silveira de Medeiros resigned from his position as a member of Embraer's Board of Directors, effective September 1, 2026. The notice explicitly states his resignation and that an alternate board member will assume the vacant position. Board-level departures are material governance events affecting the registrant's leadership structure.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 85%
filed 2026-08-20
Vale discloses that 19 additional municipalities have joined a "Definitive Agreement for the compensation and reparation of damages arising from the collapse of the Fundão dam" in Mariana, Minas Gerais (which occurred November 5, 2015). This represents a material settlement of a major environmental and legal liability affecting 45 of 49 eligible municipalities. The agreement involves waiver of lawsuits and judicial proceedings in Brazil and abroad, with significant financial obligations (lump-sum payments plus installment schedules). This is a material litigation settlement that would affect a reasonable investor's assessment of Vale's contingent liabilities and legal exposure.
View raw filing on EDGAR →
6-K
Other material
confidence 72%
filed 2026-08-20
EX-99.1
This exhibit announces S&P's upgrade of Agibank's credit rating from 'brAA-' to 'brAA' with stable outlook, completing achievement of 'AA' ratings across all three major agencies (S&P, Fitch, Moody's Local). While credit rating upgrades are positive signals reflecting improved financial health and operational performance, they do not fit neatly into the standard 8-K event taxonomy. The disclosure is material to investors as it reflects the registrant's creditworthiness and market standing, but lacks a dedicated category; it is clearly financial in nature but distinct from earnings, debt issuance, impairment, or other specific financial events.
View raw filing on EDGAR →
6-K
Terminal Other
confidence 92%
filed 2026-08-20
Braskem discloses an ongoing out-of-court debt restructuring involving US$10.3 billion in debt, with the company having filed for precautionary injunctive relief in Brazil (June 2026) and a Chapter 15 petition in the U.S. (June 26, 2026) to obtain automatic stay protection. The company is negotiating with creditors on restructuring terms including potential capitalization and asset collateral, with no final agreement reached as of August 20, 2026. This represents a material existential threat to the registrant's continued operations and solvency, warranting classification as a terminal event that does not fit the specific bankruptcy_filing category (no formal bankruptcy has been filed, only precautionary measures and Chapter 15 recognition proceedings).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds. Schedule A reports two bond issuances on trade date 8/18/2026 with settlement on 8/27/2026, each for $25 million and $15 million respectively, maturing 8/27/2029 with a 4.500% coupon. This is a classic debt issuance under Item 2.03, representing new direct financial obligations of the Federal Home Loan Bank of San Francisco.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Des Moines. Schedule A details multiple debt securities issued on trade dates in August 2026, with principal amounts totaling approximately $2.4 billion across various maturities and rate structures. This is a classic debt_issuance event under Item 2.03, and the Bank explicitly acknowledges that "consolidated obligations issuance is material to the Bank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A reports two specific debt issuances on trade date 08/18/2026: a $10 million fixed-rate bond maturing 09/12/2031 and a $50 million variable-rate discount note maturing 12/21/2026. This is a classic debt_issuance event under Item 2.03, and the filing explicitly states that "consolidated obligations issuance is material to the FHLBank."
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A lists eight separate debt issuances with trade dates of 8/17/2026 and 8/18/2026, with principal amounts ranging from $5 million to $50 million and maturities extending from 2026 to 2046. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Chicago. Schedule A details eight separate debt issuances with trade dates of 8/17/2026 and 8/18/2026, totaling approximately $1.33 billion in principal amount, with varying maturity dates, coupon rates, and call provisions. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of a direct financial obligation through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Boston. Schedule A reports a specific bond issuance with a trade date of 8/17/2026, settlement date of 8/18/2026, maturity date of 2/26/2029, a par value of $10,000,000, and a coupon rate of 4.270%. This is a material debt issuance that creates a direct financial obligation for the Bank, fitting squarely within Item 2.03 and the debt_issuance event type.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the issuance of a consolidated obligation bond by the Federal Home Loan Bank of Atlanta on trade date 8/18/2026 with a principal amount of $11,425,000, a 4.18% coupon, and maturity date of 9/17/2027. This is a direct creation of a financial obligation under Item 2.03, and the Bank explicitly states that "consolidated obligations issuance is material to the Bank." The disclosure includes detailed terms (CUSIP, settlement date, call provisions, rate type) typical of debt issuance reporting.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses that the Federal Home Loan Bank of Indianapolis has become the primary obligor on consolidated obligation bonds with a par value of $15,000,000, a 5.000% coupon, and a maturity date of 8/25/2031. This represents the creation of a direct financial obligation under Item 2.03, which is the core definition of a debt issuance event. The detailed bond terms (CUSIP, settlement date, call provisions, rate type) confirm this is a material debt obligation being assumed by the registrant.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-08-20
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Dallas. Schedule A details three bond issuances with trade dates of 8/17/2026 and 8/18/2026, totaling $70 million in par amount, with maturities ranging from 2028 to 2030. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
Item 8.01
UroGen entered into an Option and Research License Agreement with IntraGel Therapeutics on August 18, 2026, obtaining exclusive options to license IntraGel's SRGel platform for head and neck cancer treatment and other indications, coupled with a $7 million equity investment commitment. This is a material strategic partnership and licensing arrangement that expands the company's product pipeline and development capabilities, but does not constitute a traditional M&A transaction (no acquisition or change of control), debt issuance, or other specifically-named event type. It is clearly operational/strategic in nature and material to investors assessing the company's growth prospects.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-20
James E. Galeese, Executive Vice President and Chief Financial Officer, notified the Board on August 19, 2026 of his planned retirement effective August 31, 2027. The filing discloses a departure of a named executive officer in a critical financial leadership role after more than a decade of service. While the company is conducting an orderly succession search and Galeese will remain in role for approximately one year, the principal disclosed action is the departure of the CFO, making this an exec_departure event that is material to investors assessing the company's financial leadership continuity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-20
Item 2.02
LSI Industries issued a press release on August 20, 2026, announcing operating results for the fiscal quarter and full fiscal year ended June 30, 2026. The disclosure includes quarterly and full-year net sales ($234.6M and $689.4M respectively), net income ($6.9M and $22.6M), diluted EPS ($0.18 and $0.67), and adjusted EBITDA metrics. This is a standard earnings release disclosing quarterly and annual financial results, which is material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-20
Item 2.02
Twin Disc disclosed its fourth quarter and full fiscal year 2026 financial results via press release dated August 20, 2026, reporting net sales of $381.3 million (up 11.9% year-over-year), net income of $27.1 million, EBITDA of $29.9 million, and free cash flow of $9.2 million for the full year.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-20
Item 3.03
Alternus Clean Energy, Inc. completed a 1-for-2,500 reverse stock split effective August 20, 2026, approved by the Board and majority stockholders under Delaware law. The reverse split consolidated outstanding shares from approximately 724,658 to approximately 290 shares, with the stated goal of meeting minimum bid price requirements for national exchange listing and broadening investor appeal.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-20
Item 8.01
The filing discloses the appointment of Michael Richtmyer as Head of Operations for Manhattan Drug Company, Inc., a wholly owned subsidiary of Integrated BioPharma. The press release emphasizes his 35+ years of senior operations experience and his role leading "operational strategies and execution across MDC" with responsibility for manufacturing, supply chain, quality, and growth. This is a material executive appointment to a senior leadership position at a key operating subsidiary.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-08-20
Item 1.01
NexPoint Real Estate Finance entered into a First Amendment to its Mizuho loan agreement on August 17, 2026, increasing borrowing capacity from $375.0 million to $450.0 million and amending mandatory prepayment terms and covenants. The amendment also includes a Total Return Swap with $144.3 million in cash collateral transfer, materially modifying the Company's direct financial obligations and capital structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-20
Item 2.02
Super League Enterprise issued a press release on August 14, 2026 announcing its financial results for the second quarter ended June 30, 2026, including detailed financial statements, revenue metrics, gross margin expansion, and Adjusted EBITDA improvements.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
Item 7.01
Transocean announced a two-year binding Letter of Award for the Dhirubhai Deepwater KG2 drillship with ONGC in India, valued at approximately $300 million in contract value. This is a material operational and commercial event—a significant new contract award for a major offshore drilling services provider—but does not fit the specific categories of M&A activity, debt issuance, earnings release, or other named event types. The contract is a material business development milestone that would affect a reasonable investor's assessment of the company's revenue pipeline and operational capacity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-20
Item 2.02
This is a clear earnings release disclosing Q2 2026 and first-half 2026 financial results for Cosmos Health Inc., issued on August 19, 2026. The Item 2.02 disclosure explicitly states "Cosmos Health Inc. (the 'Company') issued a press release setting forth the financial results for its second fiscal quarter and six months ended June 30, 2026," with the press release attached as Exhibit 99.1. The filing includes comprehensive income statement and balance sheet data, management commentary, and business highlights—all hallmarks of a quarterly earnings release material to investors.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 88%
filed 2026-08-20
Item 1.01
ASP Isotopes' subsidiary Renergen entered into a Second Amendment and Restatement Agreement with Standard Bank on August 14, 2026, creating a secured ZAR term loan facility of approximately USD 14.2 million maturing August 14, 2027 at 8.31% interest. This amendment and restatement replaced a prior agreement and represents a material creation of direct financial obligation with cross-default provisions affecting the Company and multiple subsidiaries.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-20
The filing discloses entry into a First Amended and Restated Purchase Agreement granting an investor the right to purchase up to $75 million of unregistered common stock shares at discounted prices (95% or 75% of market price depending on trading status), increased from $25 million under the original agreement. This is a classic equity line of credit (ELOC) arrangement—an unregistered private placement of equity securities with dilutive pricing mechanics. Item 3.02 explicitly incorporates the securities description, confirming this as an unregistered equity issuance event.
View raw filing on EDGAR →
6-K
Governance Other
confidence 85%
filed 2026-08-20
The filing discloses a simultaneous departure and appointment of independent directors: Mr. Shengshan Sun resigned from the Board and all three Board committees effective August 20, 2026, and Mr. Xitian Zhang was appointed as his replacement independent director and committee member on the same date. While this involves both an exec_departure and exec_appointment, the filing presents them as a single coordinated governance action (a replacement), and the substance is a change in board composition affecting committee membership. This is material to investors as it affects board oversight and independence, though the resignation was not based on disagreement with the company.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-20
The filing discloses a firm commitment underwritten public offering of 3,437,500 shares of common stock at $3.20 per share, generating $11 million in gross proceeds. This is a registered equity issuance under an effective Form S-3 shelf registration statement, representing a material capital raise that dilutes existing shareholders. The press release explicitly states the offering is expected to close on August 21, 2026, and details the use of proceeds for R&D, sales and marketing, and working capital.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-08-20
BOXABL disclosed under Item 8.01 that it was unable to file its Form 10-Q for Q2 2026 by the required deadline due to complexities in accounting treatment for an OTC Equity Prepaid Forward Transaction (FPA). The delay in filing quarterly financial statements due to valuation and accounting complexities is a material financial event that would affect investor assessment of the company's financial reporting timeliness and the complexity of its capital structure, though it does not fit neatly into a specific financial event category.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-08-20
EX-99.1
This is a press release announcing BingEx Limited's unaudited financial results for the second quarter ended June 30, 2026. The exhibit discloses quarterly revenues (RMB940.3 million vs. RMB1,024.6 million YoY), gross profit, operating income, net loss (RMB34.0 million vs. net income of RMB53.5 million YoY), and earnings per share, along with detailed consolidated balance sheets and statements of operations. The company explicitly states "today announced its unaudited financial results for the second quarter ended June 30, 2026," and the document includes management commentary from the CEO and CFO discussing operational performance. This is a discrete earnings event, not a periodic financial report filing.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-20
The filing discloses conversion of $3,000,000 in debt into 1,829,268 shares of common stock at $1.64 per share, executed via a Debt Conversion Agreement with Rare Earth Financial, LLC. This is a dilutive equity issuance that increases share count materially. While Item 1.01 frames it as a material definitive agreement and Item 3.02 explicitly addresses unregistered equity sales, the core event is the issuance of equity securities in exchange for debt cancellation, which is a classic dilutive capital transaction.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-20
The filing discloses entry into a binding term sheet on August 16, 2026, whereby Venu Holding Corporation acquired a 50% equity interest in Hipgnosis Artist Holdings LLC and Welcome to the Machine LLC for an initial $3.25 million cash payment, with potential additional contributions up to $51.75 million contingent on a "Funding" event. This constitutes a material acquisition of equity interests under Item 1.01, forming a strategic business venture with music industry executive Merck Mercuriadis as part of the Company's content strategy for its venues.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-08-20
EX-99.1
This exhibit is a press release announcing Yunji Inc.'s unaudited financial results for the first half of 2026 (six months ended June 30, 2026). It discloses total revenues of RMB96.3 million (down 39% year-over-year), net loss of RMB72.4 million (improved from RMB100.7 million in H1 2025), and includes full unaudited condensed consolidated financial statements (balance sheet, statements of comprehensive loss, and notes). This is a discrete earnings announcement, not a periodic financial report filing itself, and is material to investors assessing the company's financial performance and operational trajectory.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
The filing discloses successful delivery and customer acceptance of an AI Cloud deployment under a ~$950M five-year contract with a global technology customer, triggering release of escrowed cash and marking a key operational milestone. This is a material operational/business event—the achievement of a major contractual deliverable for a significant customer engagement—but does not fit neatly into the specific event categories (not M&A, not earnings, not a governance change, not a financial obligation). The language emphasizes operational execution ("coordinated execution," "delivery platform," "secured and contracted capacity") and customer acceptance as a business milestone rather than a discrete financial transaction or governance matter.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-08-20
EX-99.1
PowerBank announces completion of environmental permitting for a 6.86 MW community solar project in Nova Scotia with C$14 million total development and construction cost, backed by C$4.55 million in federal and provincial grants and tax credits. The project represents a material operational milestone—completion of permitting and readiness to begin construction in Fall 2026—that advances the company's development pipeline and demonstrates execution capability in the Canadian renewable energy market. This is a discrete operational/strategic event (project milestone) rather than a periodic financial report or earnings release.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
NextTrip announced the launch of NextTrip Pro, an integrated B2B travel platform combining three complementary offerings (NextTrip Connect, NextTrip Groups, and NextTrip Ownership Rewards) designed to expand distribution through travel advisors and agencies. This is a material strategic business initiative that represents a significant expansion of the company's travel strategy and distribution model, but does not fit neatly into other specific categories—it is neither a discrete M&A transaction, earnings release, nor a governance or financial event in the traditional sense. The disclosure emphasizes this as a "scalable B2B distribution and commerce platform" and "important expansion of our travel strategy," making it a material operational/strategic event.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
Aptera announced a strategic partnership with Shanghai Launch Automotive Technology Co., Ltd. valued at approximately $44 million covering production fixtures, tooling, vehicle testing, and high-volume production work. While this involves a material commercial arrangement with a manufacturing partner, it does not constitute a traditional M&A transaction (no acquisition, merger, or change of control), nor does it fit other specific event categories. The partnership is a significant operational and strategic business arrangement that materially affects the company's path to production and capital structure (including warrant issuance), making it a material operational event.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-20
EX-99.1
This press release announces new LPG engineering subcontracts signed by Al Shola Gas (an indirect subsidiary) totaling approximately $1.4 million in project value, plus potential annual utility revenue of up to $1.0 million and a supply agreement with an Abu Dhabi hospitality group representing $817,000 to $1.09 million in potential revenue. These are material operational and commercial developments—new business wins and revenue opportunities—that do not fit the specific event categories (not M&A, not a financial obligation, not a periodic report). The disclosure is clearly operational in nature and material to investor assessment of the company's growth trajectory and cash-flow generation.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-08-20
The filing discloses a 1-for-15 reverse stock split of bioAffinity Technologies' common stock, approved by stockholders at the April 30, 2026 annual meeting and effectuated via Certificate of Amendment filed August 20, 2026. The reverse split is a governance/capital structure event intended to bring the company into compliance with Nasdaq's minimum bid price requirement. While not a named governance category (exec appointment/departure, auditor change, shareholder vote results), this is clearly a material governance matter affecting all shareholders' holdings and the company's continued listing compliance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-08-20
The filing discloses entry into a non-binding Letter of Intent (LOI) on August 19, 2026, pursuant to which Amaze Holdings proposes to acquire a 19.99% minority stake in C2 Capital Group for $3,000,000 in cash, with contingent put options for up to 1,000,000 additional shares. Although non-binding, Item 1.01 explicitly classifies this as "Entry into a Material Definitive Agreement," and the transaction contemplates a strategic investment and board seat, making it material M&A activity subject to 8-K disclosure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-20
The 8-K discloses BTCS Inc.'s financial results for Q2 2026 (quarter ended June 30, 2026) via a press release furnished as Exhibit 99.1. The filing explicitly states under Item 7.01 that "BTCS Inc. (the 'Company') issued a press release announcing its financial results for the quarter ended June 30, 2026." The press release reports total revenues of $2.4 million, gross profit of $1.5 million at 61% margin, and a net loss of $34.9 million, along with detailed segment performance and balance sheet metrics. This is a standard quarterly earnings disclosure material to investors.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-08-20
The filing discloses a share repurchase program under which Eightco repurchased approximately 14 million shares in the past two weeks under its previously announced $125 million share repurchase program. While share repurchases are technically a form of capital return to shareholders (similar to dividends), the primary focus of the press release is an operational update on the company's treasury holdings and strategic investments. However, the repurchase activity is explicitly highlighted as a material capital allocation decision, making this a dividend_distribution event (which encompasses share repurchases and returns of capital).
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-08-20
EX-99.1
This press release announces the completion of a US$4.0 million private placement of 4.0 million ordinary shares at US$1.00 per share—an unregistered equity issuance by a small-cap public company. The transaction is a classic dilutive equity raise: common shares issued in a private placement exempt from Securities Act registration, with no warrants or convertibles. The 160% premium to the prior closing price and the capital infusion are material to investors assessing the company's financial position and ownership structure.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-20
Item 3.01
Ocean Power Technologies received a notice from NYSE Regulation on August 14, 2026, stating non-compliance with continued listing standards under Section 1007 of the NYSE American Company Guide due to failure to timely file its Form 10-K by the extended due date of August 13, 2026. Although the Company cured the deficiency by filing the Form 10-K on August 19, 2026, the Item 3.01 disclosure itself documents the delisting notice and the cure period framework, which is the hallmark of delisting_risk classification. The materiality is clear: a delisting notice directly threatens the registrant's continued listing status and would significantly affect investor assessment.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-08-20
Item 5.01 discloses a Stock Purchase Agreement dated August 20, 2026, whereby Ya Deng purchased 19,300,000 shares (83.2% of voting rights on a fully-diluted basis) from Zonghan Wu at $0.015 per share, resulting in a change of control of Rocky Mountains Group Ltd. This constitutes a material acquisition or change of control event. While Item 5.02 also documents the concurrent departure of Zonghan Wu and appointment of Ya Deng, the central disclosed transaction is the change of control through the share purchase, making ma_activity the primary classification.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-20
Protagenic announced receipt of FDA written responses to its Type B pre-IND meeting request for PT00114, with FDA raising no objections to the planned Phase 1 program design, CMC, and nonclinical packages. The company plans to submit an IND before end of 2026 and target first patient dosing in H1 2027. This is a material regulatory milestone for a clinical-stage biopharmaceutical company advancing its lead product candidate, but does not fit the specific categories of earnings, M&A, impairment, litigation, or other named event types—it is a significant operational/regulatory development in the drug development pathway.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-20
Newton Golf Company entered into a Securities Purchase Agreement on August 14, 2026 for a private placement of common stock with up to $5,000,000 in aggregate proceeds (first tranche of $1,000,000 closed immediately). The shares are unregistered securities sold pursuant to Section 4(a)(2) and Regulation D exemptions to accredited investors. This is a classic dilutive equity issuance disclosed under Item 1.01 and Item 3.02, representing a material capital raise that dilutes existing shareholders.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-08-20
The filing discloses that RenovoRx received a Nasdaq non-compliance notice on December 31, 2025 for failing the Minimum Bid Price Requirement (closing bid below $1.00 for 30 consecutive business days), and subsequently regained compliance on August 20, 2026 when the stock closed at $1.00 or greater for ten consecutive business days. This is a delisting-risk event—the company was at risk of delisting and has now cured the deficiency. The materiality is clear: listing compliance directly affects investor access and trading liquidity.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-20
The filing discloses Flux Power's fiscal fourth quarter and full-year 2026 financial results under Item 2.02, with a press release (Exhibit 99.1) reporting revenue of $8.2 million for Q4 and $42.1 million for the full year, along with operating and net losses. This is a standard earnings release announcement with detailed financial statements and management commentary.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-20
The 8-K discloses quarterly financial results for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition). The press release reports significant operational and financial metrics including 510% sequential revenue growth, improved gross margins of 97.7%, 48% improvement in operating loss year-over-year, and 58% narrowing of net loss. The filing also highlights commercial milestones including the launch of REZENOPY™ as a second commercial product. This is a standard earnings release disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →